SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-052356
Filing Date
2022-10-04
Accepted
2022-10-04 17:05:02
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3387
  Complete submission text file 0001209191-22-052356.txt   5176
Mailing Address C/O UNITED AGENT GROUP, INC. 3411 SILVERSIDE RD TATNALL, BUILDING 104 WILMINGTON DE 19810
Business Address C/O UNITED AGENT GROUP, INC. 3411 SILVERSIDE RD TATNALL, BUILDING 104 WILMINGTON DE 19810 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLZMAN STREET, WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address
Stuart Iain (Reporting) CIK: 0001727756 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 221292854